# OnCo record javelin-hn-100 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/javelin-hn-100/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "javelin-hn-100", "NCT02952586" ;
  schema:name "JAVELIN Head and Neck 100"@en ;
  schema:description "Adding a PD-L1 blocker to curative chemoradiation did not help, the first of several such failures in head and neck cancer."@en ;
  schema:url <https://onco.cc/trials/javelin-hn-100/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02952586>, <https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30737-3/fulltext> ;
  onco:status "negative" ;
  onco:tag "failure", "lesson:concurrent-io-with-chemoradiation" ;
  onco:phase "3" ;
  schema:startDate "2016-11-28" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/hpv-negative-head-and-neck-cancer/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:companies <https://onco.cc/companies/merck-kgaa/>, <https://onco.cc/companies/pfizer/> .